The Human Gut Microbiome

Section

This illustration depicts a three-dimensional (3D), computer-generated image, of a group of Gram-positive, Streptococcus agalactiae (group B Streptococcus) bacteria. The photo credit for this image belongs to Alissa Eckert, who is a medical illustrator at the CDC.

By

At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki.

The insertion code consists of:
Double brackets: [[
Filename: PHIL_1181_lores.jpg
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit: Electron micrograph of the Ebola Zaire virus. This was the first photo ever taken of the virus, on 10/13/1976. By Dr. F.A. Murphy, now at U.C. Davis, then at the CDC. Every image requires a link to the source.
Closed double brackets: ]]

Other examples:
Bold
Italic
Subscript: H₂O
Superscript: Fe³⁺

Evaluation rubric
The page should have minimum 3,000 words and three figures. Number each figure and call out in text, as for example (Figure 1). Some primary research must be cited. Evaluation is based on: writing fluency, including grammar and proofreading; specific details and creative thought; and scientific understanding of microbes.

Sample citations:
A citation code consists of a hyperlinked reference within "ref" begin and end codes.
To repeat the citation for other statements, the reference needs to have a names: ". The digestive system is made up of the gastrointestinal tract-- also known as the GI tract-- liver, pancreas, and gall bladder. This anatomy is shown in figure 1. To reach the nutrients, the body must first break down the food. The first and most simple step to this process is chewing and swallowing food which then begins its pathway through the GI tract.

After being chewed and swallowed the food travel down the esophagus, then to the stomach, then to the small intestine, large intestine, and then to the anus . All the organs that make up the GI tract are hollow to allow the food to pass through. Once the food has passed through the esophagus and into the stomach it is broken down using digestive juices into a liquid form called chyme. Compared to the microbiomes of the small and large intestine, the stomach does not have a large microbiome. This is because the highly acidic environment, as well as other components created by the stomach make the stomach inhabitable for many bacteria. One notable bacterium that lives in the stomach is Helicobacter pylori (H. pylori). H. pylori is in the stomach of most humans but in some cases can cause illnesses such as gastritis or ulcers. It is unique in its ability to use enzymes to neutralize the acidic environment of the stomach.

The chyme produced by the stomach then travels through the small intestine--where most nutrients are absorbed. There are a few genera that are commonly found in the small intestine including Streptococcus and Veillonella. They are known for breaking down and metabolizing carbohydrates. They compete directly with the host for food components. These bacteria do not have a direct beneficial effect on the host, but it is possible that one bacterium, called Bacteroides thetaiotaomicron (B. thetaiotaomicron), has the ability to keep the small intestine from producing too much fucose. The microbiome of the large intesting has the largest plethora of bacteria. Once the chyme has passed into the large intestine, it is depleted of most of the nutrients and the microbes then digest what the host cannot. The large intestine introduces the chyme to a plethora of colonic bacteria. These bacteria are able to digest certain carbohydrates, particularly those from plant derived foods, that the small intestine was not able to. Vitamin B production is also a critical function of the large intestine because it sources the body with the vitamin B that is not ingested from food sources. Vitamin B also is used to produce the energy used by the large intestine. Other functions of the large intestine include, but are not limited to, water absorption via osmosis and the passing of waste to the anus.

Stomach Microbiota

Figure 2: This illustration depicts the different pH layers of the stomach lining. The innermost layer is the lumen which has the lowest pH of approximately 1-2 which makes the stomach inherently resistant to bacteria. The bottom portion of the picture depicts the epithelial cells which line the stomach. These cells are covered in lining of mucus. The mucus layer contains other defense mechanisms such as lactoferrin and antibacterial peptides that contribute to the inhibition of bacterial colonization. The photo credit for this image belongs Algood et al from the National Library of medicine NIH.

The main purpose of the stomach is to further break down the chewed food. The stomach is able to do this by producing digestive juices made up of stomach acid and enzymes from glands in the stomach lining. Many studies have analyzed the digestive juices for their microbiota. A study done by Bik et al in 2005 analyzed the stomach microbiota for the first time using a small subunit 16S rDNA clone library approach and found five dominant genera including Streptococcus, Prevotella, Rothia, Fusobacterium and Veillonella. Other studies conducted in later years using the same method found other genera including Neisseriae, Haemophilus, Porphyromonas, Rothia, Propionibacterium, and Lactobacillus.

However, many of these bacteria may be transient in the stomach since the stomach is open to a swelling of bacteria from the oral cavity. For example, Lactobacilli is known to be present in the mouth for the purpose of converting the nitrate found in food and saliva into nitrite which can be converted into nitric oxide by gastric juice in the stomach to produce a useful antimicrobial agent . Most microbes in general do not survive in the stomach due to its high acidity. On top of its high acidity, the stomach utilizes its gastric mucosa to produce other factors to kill bacteria that are transported from the oral cavity including peptides B-defensins 1 and 2 and LL-37 as shown in figure 2. These peptides fight off many species of bacteria. Also, an enzyme called lysozyme degrades bacterial peptidoglycan. Proteins in the stomach can also inhibit bacterial growth including lactoferrin and surfactant protein D. Lactoferrin inhibits bacterial colonization by reducing extracellular Fe3+ and surfactant protein D brings the bacteria into close proximity to each other. Finally, other mucosal components such as alpha-1,4-GluNAC-capped O-glycans, which disrupt the biosynthesis of cholesteryl-α-D-glucopyranoside, a component of the H. pylori cell wall . Many bacteria that are specialized to live within the human stomach are still unknown, but among the 128 identified phylotypes identified by Bik et al in 2005, one particularly interesting sequence identified was that belonging to Deinococcus/ Thermus phylum. This phylum is known to live in extreme environments such as hot springs and radioactive sites.

Although much is still unknown about the stomach microbiota, one famous bacterium in the stomach is H. pylori. About 50% of the human population is known to be infected with this bacterium, but most have no symptoms. H. pylori is associated with an increased risk of duodenal ulcer disease, gastric ulcer disease, gastric adenocarcinoma, and gastric lymphoma. H. pylori is a gram-negative bacterium that elicits humoral and cellular immune responses. H. pylori is the only known bacteria to colonize in the gastric mucosa and crosstalk with the host. It does not partake in nutrient absorption but instead is the known cause of gastritis. It can survive the highly acidic environment by using its urease enzyme to produce ammonia and neutralize the acid . Strains of H. pylori that can cause infection have flagella that mobilize it so that it can pass from the lumen, which has a pH between 1-2 to the mucus layer that lines the epithelial cells and has a pH of 2. It is then able to travel through the mucus layer to its ideal environment on the epithelial cell surface which has a pH of 6 . The bacteria is able to attach on to the cell surface via outer membranes proteins that include BabA, SabA, AlpA, AlpB, and HopZ. This adherence allows for the activation of signaling pathways that allow for toxins to enter the cells which incurs gastric mucosal inflammation, production of autoantibodies, and parietal cell loss.

Small Intestine

Figure 3: This figure depicts the regulation of glycan production in the ileum of germ free mice. The light green represents no UEA-I staining while the brown and purple show staining, meaning that glycan was produced(A). The bottom image shows the gene line up and how the L-fucose inducer acts as both an inducer and a co-repressor. The photo credit for this image belongs Hooper et al from the National Library of medicine NIH.

After being liquified, the stomach contents enter the next phase of the GI tract, the small intestine. Nutritional uptake occurs mainly in the small intestine. The most prominent genera of bacteria are Streptococcus and Veillonella. Cultured isolates of the Streptococcus genus include S. mitis, S. bovis (s equnis), and S. salivaris. These bacteria metabolize sugars that come from food components in order to release immune responses in the gut. S. mitis metabolizes N-acetyl glucosamine and raffinose. S. bovis metabolizes L-Arabinose and raffinose. S. salvarius metabolizes L-Arabinose and Trehalose . A study done by Bogert et al in 2013 analyzed both Streptococcus and Veillonella strains of bacteria found in the human small intestine and concluded that it is possible that Streptococcus populations play a major role in the primary carbohydrate metabolism in the small intestine . Veillonella, on the other hand, ferment the lactic acid that is produced by streptococci to create acetic acid and propionic acid . A 2012 study conducted by Zoetendal et al concluded that the microbiome of the small intestine is highly dependent on available carbohydrates, which supports Bogert et al’s findings that Streptococcus is responsible for carbohydrate metabolism. Zoetendal et al did a comparative functional analysis to determine that simple carbohydrate transport phosphotransferase systems, central metabolism, and biotin production are represented in the small intestine . It is important for these bacteria to have strong metabolism pathways because they directly compete with the host.

An example of a possible symbiotic relationship between the human small intestine and bacteria is that of the B. thetaiotaomicron life cycle. It has been demonstrated in mice that there is fucosylated glycan production in the distal small intestine. B. thetaiotaomicron has evolved to be able to sense the availability of carbohydrates in the surrounding environment and use fucose as an energy source. It picks up fucose, which is a terminal a-linked sugar, by secreting an enzyme called a-frucosidase to obtain the monosaccharide fucose and import it as well as metabolize it. When the bacteria sense a scarcity of fructose, specifically, in the lumen it makes the gut epithelium express fucosylated glycans at a higher rate so that it can use them as an energy source . This signaling pathways is shown in figure 3. When L-fucose (fucose) is present it acts as a corepressor by binding to the control of signal production (csp) and stops the host from producing more fucose. The fucose acts through FucR, which is a repressor that is a molecular sensor of fucose availability . This tightly coordinated relationship between the host and the bacteria keep the host from overproducing hydrolysable epithelial fucose. It is possible that this relationship also benefits the health of the small intestine by disallowing the colonization of pathogens that are fucosylated glycan-adhesive.

Large Intestine

Figure 4: This figure depicts the metabolism pathways of P. copri. P.copri can carry out the pentose metabolism pathway or the sedoheptulose-1,7-bisphosphate pathway. Both processes begin with Ru5P and end in glycolysis. The photo credit for this image belongs Basen et al from the FEBS Press FEBS.

One the food contents pass through the small intestine they enter the large intestine, which is approximately five feet long. At this point the food contents are mostly nutrient depleted. The large intestine has three main functions including absorbing water and electrolytes, producing and absorbing vitamins, and forming and moving waste toward the anus. Water absorption is conducted by osmosis and sodium and other elements are absorbed through biochemical channels. Motility of waste is conducted by smooth muscle with the aid of mucus layers. The production and absorption of vitamins, on the other hand, are highly dependent on bacteria. Colonic bacteria most famously produce vitamins B and K . Colonic bacteria use both diet derived and host-derived food sources for energy and growth. They contain significantly more genes than humans that or able to digest food components. Most of their metabolism is done through fermentation.

Figure 5: This figure depicts a traditional pathway of glutamate fermentation in C. tetanomorphum. Five pyruvates produce two butyrates. The photo credit for this image belongs Herrmann et al (2008) from the Journal of Bacteriology Bacteriology.

Some carbohydrates, including those in plant-derived foods, cannot be digested in the small intestine and therefore are available for microbial digestion in the large intestine. Pentose is fermented via Prevotella copri (P. copri). P. copri, which is a part of the Bacteroidetes phylum, uses plant-derived fibers to produce acetate, formate, and succinate . Genes encoded in P. copri are used to uptake pentose and convert it into important intermediates including L-ribulose-5-phosphate (Ru5P) and D-xylulose-5-P (Xu5P). Ru5P and Xu5P are converted into glyceraldehyde-3-phosphate (G3P/GAP), and fructose-6-phosphate (F6P) via the pentose phosphate pathway (PPP) . The PPP is a fundamental component of cellular metabolism that has a purpose of reducing molecules for anabolism and reducing oxidative stress . The enzymes used in the PPP are transketolase and transaldolase. Transketolase and the same starting intermediate, Ru5P, can be used start the Sedoheptulose-1,7-biphosphate pathways which, also using PPi-PFK and FBP adolase, produce the same products as PPP. These products, F6P and G3P can enter the glycolysis cycle to be further oxidized using the DHAP anion. The product of glycolysis is pyruvate. Figure 4 shows a diagram of these pathways .

Byruvate formation takes place in the large intestine mostly vis gram-positive anaerobic firmicutes. The two most abundant groups in the large intestine are Eubacterium rectale/ Roseburia spp. and to Faecalibacterium prausnitzii. Byruvate is an important component of the large intestine because it is a main energy source for colonic mucosa and regulates gene expression, inflammation, and apoptosis. More specifically, it can activate the AP-1 signaling pathway in epithial cells by interacting dirst with human cell receptors FFAR2 and FFAR3. The AP-1 pathway controls a number of cellular processes such as cellular differentiation, proliferation, and apoptosis. This interaction can protect against diet-induced obesity by improving insulin sensitivity. Butyrate-producing bacteria carry out fermentative metabolism and can also produce lactate, formate, hydrogen and carbon dioxide. A hypothetical scheme of butyrate production is shown in figure 5. It was proposed by Herman et al in 2008 that as well as regenerating NAD+ from NADH, that the production of butyrate may also produce a proton motive force with NADH and ferredoxin oxidoreductase . An example of a specific bacteria that plays a major role in the degradation of xylan is Roseburia intestinalis. This bacterium, as well as E. rectale thrive at a pH of 5.5. The large intestine microbiome is heavily dependent on the hosts diet since much of the microbe’s energy source is dependent on chyme. Resistant starch intake increases the butyrate production in the bacteria .

Vitamin B Production in the Large Intestine

The production of vitamin B is also credited to colonic microbes. The human body only needs a very small dose (about 1 ug/day) to help with two enzymes, methionine synthase and (R)-methylmalonyl-CoA mutase . In the small intestine alkaline phosphatase converts thiamine pyrophosphate (TPP), which is the form of vitamin B1 found in lots of meats, eggs, rice bran, and beans, into free thiamine. Thiamine transporters then assist to the intestinal epithelium to absorb the free thiamine which then enters the bloodstream and gets delivered to the necessary places throughout the body. This thiamine is reverted back to TPP to be used for the TCA cycle as energy .

Food is a major source of vitamin B1 intake. However, the microbiota of the human colon is also capable of producing it. The human colon holds a diverse microbiota that produces vitamin B1, B2, B3, B4, B5, B6, B7, B9, and B12. The vitamin B1 producers are Bacteroides fragilis and Prevotella copri (phylum Bacteroidetes); Clostridium difficile, some Lactobacillus spp., and Ruminococcus lactaris (Firmicutes); Bifidobacterium spp. (Actinobacteria); and Fusobacterium varium . These bacteria contain genomes that encode for enzymes that synthesize precursors to thiamine, particularly TPP . These precursors are also responsible for the production of thiazole and pyrimidine. Because of the lack of alkaline phosphatase in the colon, free thiamine cannot be produced. So, TPP transporters help the colon absorb the TPP which then enters mitochondria which is used for ATP generation. This energy goes to the colon. However, there is some competition for vitamin B1 in the colon because some firmicutes, such as Faecalibacterium spp., lack the full synthesis pathway for vitamin B1. Faecalibacterium live in the colon and do not produce vitamin B1, but actually require it for growth. Therefore, they must compete with the human colon for it .

Vitamin B12, like vitamin B1, can be either produced in the colon or absorbed from food in the small intestine. Vitamin B12 is an important factor, along with vitamin B6 and B9 to form red blood cells and nucleic acids. Vitamin B12 from food sources is absorbed into the epithelial cells of the small intestine via an intrinsic factor. It is produced in the colon from Bacteroides fragilis and Prevotella copri (Bacteroidetes); Clostridium difficile, Faecalibacterium prausnitzii and Ruminococcus lactaris (Firmicutes); Bifidobacterium animalis, B.infantis, and B.longum (Actinobacteria); Fusobacterium varium (Fusobacteria). These bacteria are capable of this production via either an aerobic or anaerobic process .

The gut microbiota contains significantly more enzymes that are able to digest food than the human genome contains. So, having gut bacteria is critical to a healthy human. The beginning parts of the GI tract help to break down food and digest what the human enzymes are capable to metabolizing, and then once the chyme enters the large intestine the majority of the microbes take over. The body only excretes what both the human and microbial enzymes are unable to digest. A healthy diet helps to sustain a diverse microbial environment; however, some bacteria can over grow in the gut and cause problems to the host. H. pylori is an example of one bacterium that can overgrow in the stomach and cause gastritis. However, there are other bacteria as well that can even be fatal such as Clostridium difficile (C. diff). C. difficile can be commonly found in healthy infants but should be undetectable in healthy adults . This is one example of how bacteria can be beneficial in some environments and harmful in others. Depending on the environment some bacteria that may be beneficial is very small amount may be very harmful in large amounts. A diverse gut microbiota helps to keep each species in check to meet the needs of both the host and themselves.

References

Authored for BIOL 238 Microbiology, taught by Joan Slonczewski, 2023, Kenyon College